GE HealthCare Q3 2025 Financial Results

GE HealthCare Technologies Inc. reported its third quarter 2025 financial results, showing a 6% increase in revenue and 4% organic revenue growth year-over-year. The growth was driven by strong performance in Europe, the Middle East, and Africa (EMEA) and the U.S. The company achieved a net income margin of 8.7% and an adjusted EBIT margin of 14.8%. Diluted earnings per share (EPS) were $0.98, while adjusted EPS was $1.07. Cash flow from operating activities was $593 million, and free cash flow was $483 million. The company raised the lower end of its full-year 2025 adjusted EPS guidance range and reaffirmed other financial metrics.